TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research March 1, 1974
TCL Archive Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested February 11, 1977